mRNA |
KX2-391 |
CTRPv2 |
pan-cancer |
AAC |
0.081 |
0.01 |
mRNA |
SNS-032 |
CTRPv2 |
pan-cancer |
AAC |
0.089 |
0.01 |
mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.089 |
0.02 |
mRNA |
Nutlin-3 |
CTRPv2 |
pan-cancer |
AAC |
-0.076 |
0.03 |
mRNA |
PIK-93 |
CTRPv2 |
pan-cancer |
AAC |
0.077 |
0.03 |
mRNA |
Gemcitabine |
gCSI |
pan-cancer |
AAC |
0.12 |
0.03 |
mRNA |
GDC-0941 |
CTRPv2 |
pan-cancer |
AAC |
0.079 |
0.03 |
mRNA |
Nilotinib |
CTRPv2 |
pan-cancer |
AAC |
-0.079 |
0.03 |
mRNA |
BRD-K51490254 |
CTRPv2 |
pan-cancer |
AAC |
0.08 |
0.03 |
mRNA |
navitoclax:pluripotin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.077 |
0.03 |